DK0538302T3 - Reduktion eller forhindring af hudirritation forårsaget af lægemidler - Google Patents
Reduktion eller forhindring af hudirritation forårsaget af lægemidlerInfo
- Publication number
- DK0538302T3 DK0538302T3 DK91912369.5T DK91912369T DK0538302T3 DK 0538302 T3 DK0538302 T3 DK 0538302T3 DK 91912369 T DK91912369 T DK 91912369T DK 0538302 T3 DK0538302 T3 DK 0538302T3
- Authority
- DK
- Denmark
- Prior art keywords
- drug
- skin
- irritation
- prevention
- mucosa
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Passenger Equipment (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Packaging For Recording Disks (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/549,584 US5130139A (en) | 1990-07-06 | 1990-07-06 | Reduction or prevention of skin irritation by drugs |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0538302T3 true DK0538302T3 (da) | 1995-09-18 |
Family
ID=24193593
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK91912369.5T DK0538302T3 (da) | 1990-07-06 | 1991-07-01 | Reduktion eller forhindring af hudirritation forårsaget af lægemidler |
Country Status (18)
Country | Link |
---|---|
US (1) | US5130139A (da) |
EP (1) | EP0538302B1 (da) |
JP (1) | JP3224814B2 (da) |
AT (1) | ATE121627T1 (da) |
AU (1) | AU641787B2 (da) |
CA (1) | CA2046014C (da) |
DE (1) | DE69109292T2 (da) |
DK (1) | DK0538302T3 (da) |
ES (1) | ES2071322T3 (da) |
FI (1) | FI930038A0 (da) |
GR (1) | GR3015934T3 (da) |
IE (1) | IE74152B1 (da) |
MX (1) | MX9100042A (da) |
NO (1) | NO925038L (da) |
NZ (1) | NZ238804A (da) |
PT (1) | PT98177B (da) |
WO (1) | WO1992000746A1 (da) |
ZA (1) | ZA915067B (da) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2100074C (en) * | 1991-11-08 | 2003-08-12 | Yasushi Sekiyama | Biocidal self-adhesive and process for producing the same, as well as self-adhesive article and application thereof |
US5843979A (en) * | 1993-02-25 | 1998-12-01 | Bristol-Myers Squibb Company | Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity |
US6190894B1 (en) | 1993-03-19 | 2001-02-20 | The Regents Of The University Of California | Method and compositions for disrupting the epithelial barrier function |
IL109036A (en) * | 1993-03-19 | 1998-12-27 | Cellegy Pharamaceuticals Inc | Preparations for detachment of the epithelial barrier function and use of means for the preparation of such preparations |
US5451407A (en) * | 1993-06-21 | 1995-09-19 | Alza Corporation | Reduction or prevention of skin irritation or sensitization during transdermal administration of a irritating or sensitizing drug |
JP3549540B2 (ja) * | 1994-03-30 | 2004-08-04 | アルザ・コーポレーション | 電気的移送式投与中の皮膚刺激状態の軽減 |
WO1995034262A1 (en) * | 1994-06-16 | 1995-12-21 | Department Of The Army, Us Government | Transdermal treatment of malaria |
US5686100A (en) * | 1994-11-22 | 1997-11-11 | E.R. Squibb & Sons, Inc. | Prophylactic and therapeutic treatment of skin sensitization and irritation |
WO1997047355A1 (en) * | 1996-06-12 | 1997-12-18 | Alza Corporation | Reduction of skin sensitization in electrotransport drug delivery |
US6512010B1 (en) * | 1996-07-15 | 2003-01-28 | Alza Corporation | Formulations for the administration of fluoxetine |
US5981168A (en) * | 1998-05-15 | 1999-11-09 | The University Of British Columbia | Method and composition for modulating amyloidosis |
US6699497B1 (en) * | 1998-07-24 | 2004-03-02 | Alza Corporation | Formulations for the transdermal administration of fenoldopam |
US20040258742A1 (en) * | 2003-04-11 | 2004-12-23 | Van Osdol William Woodson | Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidines |
US7780981B2 (en) | 2004-09-13 | 2010-08-24 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery |
US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
US20070042026A1 (en) * | 2005-03-17 | 2007-02-22 | Wille John J | Prophylactic and therapeutic treatment of topical and transdermal drug-induced skin reactions |
WO2006127905A2 (en) | 2005-05-24 | 2006-11-30 | Chrono Therapeutics, Inc. | Portable drug delivery device |
JP2010516556A (ja) | 2007-01-25 | 2010-05-20 | 本田技研工業株式会社 | 車両の安定性を改善するための車両システムの制御方法 |
EP2729148A4 (en) | 2011-07-06 | 2015-04-22 | Parkinson S Inst | COMPOSITIONS AND METHODS FOR TREATING SYMPTOMS IN PATIENTS WITH PARKINSON'S DISEASE |
US10105487B2 (en) | 2013-01-24 | 2018-10-23 | Chrono Therapeutics Inc. | Optimized bio-synchronous bioactive agent delivery system |
RU2675360C2 (ru) * | 2013-02-08 | 2018-12-19 | Луода Фарма Лимитед | Способы лечения местных микробных инфекций |
CA2974324A1 (en) | 2015-01-28 | 2016-08-04 | Zita S. Netzel | Drug delivery methods and systems |
CA2977814A1 (en) | 2015-03-12 | 2016-09-15 | Chrono Therapeutics Inc. | Craving input and support system |
CA3049529A1 (en) | 2017-01-06 | 2018-07-12 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
JP7420797B2 (ja) | 2018-05-29 | 2024-01-23 | モーニングサイド ベンチャー インベストメンツ リミテッド | 薬剤送達の方法及びシステム |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3598122A (en) * | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
US3598123A (en) * | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
US3991755A (en) * | 1973-07-27 | 1976-11-16 | Medicon, Inc. | Iontophoresis apparatus for applying local anesthetics |
US4274420A (en) * | 1975-11-25 | 1981-06-23 | Lectec Corporation | Monitoring and stimulation electrode |
US4141359A (en) * | 1976-08-16 | 1979-02-27 | University Of Utah | Epidermal iontophoresis device |
US4325367A (en) * | 1977-06-13 | 1982-04-20 | Robert Tapper | Iontophoretic treatment apparatus |
US4250878A (en) * | 1978-11-22 | 1981-02-17 | Motion Control, Inc. | Non-invasive chemical species delivery apparatus and method |
CA1153427A (en) * | 1978-12-11 | 1983-09-06 | Patrick T. Cahalan | Tape electrode |
JPS56501274A (da) * | 1979-10-10 | 1981-09-10 | ||
US4286592A (en) * | 1980-02-04 | 1981-09-01 | Alza Corporation | Therapeutic system for administering drugs to the skin |
US4314557A (en) * | 1980-05-19 | 1982-02-09 | Alza Corporation | Dissolution controlled active agent dispenser |
US4379454A (en) * | 1981-02-17 | 1983-04-12 | Alza Corporation | Dosage for coadministering drug and percutaneous absorption enhancer |
JPS5810066A (ja) * | 1981-07-10 | 1983-01-20 | 株式会社アドバンス | イオントフオレ−ゼ用プラスタ−構造体 |
US4419092A (en) * | 1981-11-06 | 1983-12-06 | Motion Control, Inc. | Iontophoretic electrode structure |
GB2124485B (en) * | 1982-08-04 | 1986-06-04 | Michael A Levy | Penetrating topical medicament |
US4559222A (en) * | 1983-05-04 | 1985-12-17 | Alza Corporation | Matrix composition for transdermal therapeutic system |
US4557723A (en) * | 1983-08-18 | 1985-12-10 | Drug Delivery Systems Inc. | Applicator for the non-invasive transcutaneous delivery of medicament |
US4708716A (en) * | 1983-08-18 | 1987-11-24 | Drug Delivery Systems Inc. | Transdermal drug applicator |
US4640689A (en) * | 1983-08-18 | 1987-02-03 | Drug Delivery Systems Inc. | Transdermal drug applicator and electrodes therefor |
US4573995A (en) * | 1984-10-09 | 1986-03-04 | Alza Corporation | Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine |
US4702732A (en) * | 1984-12-24 | 1987-10-27 | Trustees Of Boston University | Electrodes, electrode assemblies, methods, and systems for tissue stimulation and transdermal delivery of pharmacologically active ligands |
FR2605221B1 (fr) * | 1986-10-20 | 1989-09-01 | Sanofi Sa | Compositions pharmaceutiques ou veterinaires contenant de la de(hydroxymethyl)-25 deoxy-25 oxo-25 monensine |
AU610839B2 (en) * | 1986-11-07 | 1991-05-30 | Purepac, Inc | Transdermal administration of amines |
US4983395A (en) * | 1987-11-12 | 1991-01-08 | Theratech Inc. | Device for administering an active agent to the skin or mucosa |
US4885154A (en) * | 1988-03-01 | 1989-12-05 | Alza Corporation | Method for reducing sensitization or irritation in transdermal drug delivery and means therefor |
US4855294A (en) * | 1988-09-06 | 1989-08-08 | Theratech, Inc. | Method for reducing skin irritation associated with drug/penetration enhancer compositions |
US4908213A (en) * | 1989-02-21 | 1990-03-13 | Schering Corporation | Transdermal delivery of nicotine |
IE902182A1 (en) * | 1989-06-19 | 1991-01-02 | Wellcome Found | Medicaments |
-
1990
- 1990-07-06 US US07/549,584 patent/US5130139A/en not_active Expired - Lifetime
-
1991
- 1991-06-28 CA CA002046014A patent/CA2046014C/en not_active Expired - Fee Related
- 1991-07-01 WO PCT/US1991/004685 patent/WO1992000746A1/en active IP Right Grant
- 1991-07-01 DK DK91912369.5T patent/DK0538302T3/da active
- 1991-07-01 MX MX9100042A patent/MX9100042A/es not_active IP Right Cessation
- 1991-07-01 DE DE69109292T patent/DE69109292T2/de not_active Expired - Fee Related
- 1991-07-01 IE IE229491A patent/IE74152B1/en not_active IP Right Cessation
- 1991-07-01 EP EP91912369A patent/EP0538302B1/en not_active Expired - Lifetime
- 1991-07-01 AU AU81046/91A patent/AU641787B2/en not_active Ceased
- 1991-07-01 JP JP51195691A patent/JP3224814B2/ja not_active Expired - Fee Related
- 1991-07-01 AT AT91912369T patent/ATE121627T1/de not_active IP Right Cessation
- 1991-07-01 ES ES91912369T patent/ES2071322T3/es not_active Expired - Lifetime
- 1991-07-01 ZA ZA915067A patent/ZA915067B/xx unknown
- 1991-07-01 NZ NZ238804A patent/NZ238804A/en unknown
- 1991-07-01 PT PT98177A patent/PT98177B/pt not_active IP Right Cessation
-
1992
- 1992-12-30 NO NO92925038A patent/NO925038L/no unknown
-
1993
- 1993-01-05 FI FI930038A patent/FI930038A0/fi not_active Application Discontinuation
-
1995
- 1995-04-27 GR GR940403851T patent/GR3015934T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO1992000746A1 (en) | 1992-01-23 |
CA2046014C (en) | 2003-05-20 |
GR3015934T3 (en) | 1995-07-31 |
ES2071322T3 (es) | 1995-06-16 |
EP0538302B1 (en) | 1995-04-26 |
US5130139A (en) | 1992-07-14 |
JP3224814B2 (ja) | 2001-11-05 |
FI930038A (fi) | 1993-01-05 |
IE912294A1 (en) | 1992-01-15 |
IE74152B1 (en) | 1997-07-02 |
NZ238804A (en) | 1992-08-26 |
NO925038D0 (no) | 1992-12-30 |
JPH05508643A (ja) | 1993-12-02 |
CA2046014A1 (en) | 1992-01-07 |
EP0538302A1 (en) | 1993-04-28 |
AU8104691A (en) | 1992-02-04 |
NO925038L (no) | 1993-01-06 |
PT98177B (pt) | 1998-12-31 |
ATE121627T1 (de) | 1995-05-15 |
DE69109292D1 (de) | 1995-06-01 |
DE69109292T2 (de) | 1995-08-31 |
AU641787B2 (en) | 1993-09-30 |
FI930038A0 (fi) | 1993-01-05 |
ZA915067B (en) | 1992-04-29 |
PT98177A (pt) | 1993-08-31 |
MX9100042A (es) | 1992-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0538302T3 (da) | Reduktion eller forhindring af hudirritation forårsaget af lægemidler | |
WO1992002234A3 (en) | Reduction or prevention of sensitization to drugs | |
ATE429904T1 (de) | Topisch anwendbare arzneipräparate und verfahren zur behandlung | |
WO2004056305A3 (en) | Administration of capsaicinoids | |
ATE292982T1 (de) | Analgesiche synergie durch gleichzeitige verabreichung von subanalgesichen doseneines mu- opioidanagonisten und eines kappa - 2- opioidanagonisten | |
EE9700132A (et) | Inhalatsiooniseade, meetod farmatseutilise toimeaine pihustamiseks ning meetod farmatseutilise toimeaine doosi manustamiseks | |
WO1994008551A3 (en) | Pharmaceutical compositions and methods for treating cold symptoms | |
YU215090A (sr) | Formulacija u obliku pilule za kontrolisano oslobađanje | |
AU4923500A (en) | Device and method for increasing the transdermal permeation of medicaments | |
DE60100994D1 (de) | Transdermales therapeutisches System für die Erzielung hoher Plasmaspiegel von Rotigotin in der Therapie von Morbus Parkinson | |
SE0002754D0 (sv) | New pharmaceutical combination formulation and method of treatment with the combination | |
SE9601528D0 (sv) | Transdermally administered dextromethorphan as antitissue agent | |
ATE311928T1 (de) | (-)-pseudoephedrin als sympathomimetisches arzneimittel | |
BRPI0409699A (pt) | métodos de indução do efeito diurético, de indução, manutenção ou restauração do efeito diurético de diurético não modificador de adenosina, de manutenção, restauração ou melhoria da função renal em paciente, de indução de diurese, de prevenção do inìcio de deficiência renal em paciente com sobrecarga de fluidos ou chf, de tratamento de paciente que sofre de chf e de melhoria dos resultados globais da saúde, composição farmacêutica e seus usos | |
BR0307022A (pt) | Método de tratamento de um paciente que precisa de analgesia | |
DK0799618T3 (da) | Anvendelse af alpha1-adrenoreceptor-antagonister i fremstillingen af et medikament til forebyggelsen og behandlingen af cancer | |
CY1106702T1 (el) | Χρηση ενος συνδυασμου μιας πουρινης και ενος παραγοντα δοτη μονοξειδιου του αζωτου για την προληψη ή την αγωγη γενετησιων δυσλειτουργιων | |
BR0311180A (pt) | Métodos para o tratamento de doenças e condições respiratórias utilizando um inibidor seletivo da inos | |
HUP9901935A2 (hu) | Gyógyszerek és terápiás szerek és más glikozaminoglikánok (GAG) dózisainak célbajuttatására alkalmas dóziskészlet | |
PT1083900E (pt) | Utilizacao de oxazolididonas para a preparacao de um medicamento para entrega transdermica | |
BR9914792A (pt) | Uso de agentes antifúngicos para tratamento deescleroses | |
IL110888A (en) | Pharmaceutical compositions for the treatment of liver diseases comprising a vasodilating compound | |
RU2002129097A (ru) | Комбинированные терапии с использованием активности, повреждающей сосуды |